Suppliers / Lantech Pharmaceuticals

Lantech Pharmaceuticals

Updated 9 July 2026

Lantech Pharmaceuticals is an API manufacturer. It holds one active US drug master file. Customs aggregates show $1K of exports covering 1 molecule to 1 destination in 2023.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Lamivudine US FDA 1

Also appears on these molecule pages

Scale

Year Revenue Exports Destinations
2023 Not reported $1K 1
2022 Not reported $388K 4

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Lantech Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts